345. 乳児発症STING関連血管炎 Disease details / Clinical trials / Drug dev / DR info /

臨床試験数 : 5 / 薬物数 : 3 - (DrugBank : 1) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 37

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
Baricitinib
   Eli Lilly and Company
      2020   Phase 2/Phase 3   NCT04517253   Japan
      2012   -   NCT01724580   United Kingdom;United States
      -   Phase 2;Phase 3   EUCTR2025-000001-16-Outside-EU/EEA   Japan
      -   Phase 2   EUCTR2015-003424-31-GB   France;United Kingdom;United States
   Masaki Takeshi
      2020   Phase 2-3   JPRN-jRCT2031200152   -
LY3009104
   Eli Lilly and Company
      -   Phase 2;Phase 3   EUCTR2025-000001-16-Outside-EU/EEA   Japan
      -   Phase 2   EUCTR2015-003424-31-GB   France;United Kingdom;United States
Olumiant
   Eli Lilly and Company
      -   Phase 2;Phase 3   EUCTR2025-000001-16-Outside-EU/EEA   Japan